Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- Check6 days agoChange DetectedThe page now displays the HY209 Phase I atopic dermatitis study record, including its design, eligibility criteria, locations, outcomes, and study documents, rather than an access-denied error.SummaryDifference50%

- Check13 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2, while the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces the NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now shows a 403 error, replacing the full study record content with a minimal error page and a Home link, effectively making the NCT03492398 record inaccessible and hiding all associated study information.SummaryDifference18%

- Check62 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, signaling a newer version of the page's content.SummaryDifference0.1%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.